He was seen multiple times in the [**Hospital6 6689**] ER and diagnosed with pneumonia and treated with courses of antitbiotics.
He notes two episodes, the last of which he produced approximately a "cupful" of blood clots and bright red blood.
Physical Exam: Vitals: T 97.4 BP 112/78 HR 94 RR 20 97% RA Gen: Cachectic African American man, in NAD HEENT: PERRL, EOMI, mmm, OP clear Neck: supple, FROM, no JVD Lung: decreased breath sounds in left lower lung fields, otherwise CTA bilaterally Cor: RRR, nml S1S2, no m/r/g Abd: NABS, soft NTND Ext: no c/c/e   Pertinent Results: Chemistries: [**2141-9-2**] 09:15PM   GLUCOSE-87 UREA N-10 CREAT-1.0 SODIUM-139 POTASSIUM-4.2 CHLORIDE-102 TOTAL CO2-27 ANION GAP-14 [**2141-9-2**] 09:15PM   ALBUMIN-4.0 CALCIUM-9.7 PHOSPHATE-3.6 MAGNESIUM-2.0  LFTs: [**2141-9-2**] 09:15PM   ALT(SGPT)-12 AST(SGOT)-29 CK(CPK)-162 ALK PHOS-89 AMYLASE-184* TOT BILI-0.2 [**2141-9-2**] 09:15PM   LIPASE-251*  Cardiac Enzymes: [**2141-9-2**] 09:15PM   cTropnT-<0.01 [**2141-9-2**] 09:15PM   CK-MB-3  CBC: [**2141-9-2**] 09:15PM   WBC-8.8 RBC-4.43* HGB-14.3 HCT-40.6 MCV-92 MCH-32.3* MCHC-35.3* RDW-12.8 [**2141-9-2**] 09:15PM   NEUTS-68.4 LYMPHS-25.6 MONOS-3.2 EOS-1.8 BASOS-1.1 [**2141-9-2**] 09:15PM   PLT COUNT-288  STUDIES: CTA ([**Hospital1 18**] [**2141-9-3**]): Large left hilar mass extending to the mediastinum, with narrowing of the pulmonary arteries and left bronchial branches.
He was started on decadron per onc/rad onc.
The slides from the OSH were received and felt to be c/w SCLC so a family meeting was held and it was decided to start chemo on [**9-8**] and proceed with xrt after the 2nd cycle of chemo.
Patient with squamous cell lung cancer with metastases to brain and pancreas.
Patient's treatment for squamous cell lung cancer was on hold due to his pancreatitis, ventilator requirement, and acute illness.
Given patient's continued pancreatitis, heme-onc was again consulted who recommended that chemotherapy would likely not be an option for this patient due to his continued illness.
Family was made aware of this and preferred that patient would not receive further treatment.
Given the continued elevated amylase and lipase, hematology-oncology did not believe chemotherapy would be an option for him.
He then had a MRCP that show mass in pancreatic duct.Patient received 4L of NS on [**2141-9-11**].
He was transferred to ICU for management of respiratory distress.
Medicine service hospital course after transfer from ICU on [**2141-9-29**]:  # Comfort measures only: patient not in distress,normal resp rate, did not check daily vitals Acetaminophen Haloperidol Lorazepam Morphine Sulfate, titrate to comfort Scopolamine Patch  # Respiratory failure s/p extubation in ICU, sats low prior to transfer  # SCLC No treatment options  # MRSA No antibiotics given goals of care.
Medications on Admission: 1000 ml 1/2NS D5 Levofloxacin 500 mg PO Q24H D5 Flagyl 500 mg po tid Albuterol 0.083% Neb Soln 1 NEB IH Q6H Benzonatate 100 mg PO TID Dexamethasone 4 mg IV Q6H Hydromorphone 0.5-1 mg SC Q3-4H:PRN Hydromorphone 2-4 mg PO Q4H:PRN Insulin SC  Discharge Medications: None  Discharge Disposition: Extended Care  Discharge Diagnosis: Squamous Cell Lung Cancer Small cell lung cancer with metastases to brain/skull/rib Respiratory failure Pancreatitis .
